Case File
efta-efta01521223DOJ Data Set 10CorrespondenceEFTA Document EFTA01521223
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01521223
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
CHISLAINE MAXWELL
ACCT.
For the Period 5/1/12 to
Equity Summary
Asset Categories
US Large Cap Equity
58320.07
55.459.33
(2.860.74)
1%
US Small/Mid Cap Equity
5.025.00
3.930.00
(1.095.00)
1%
Non-US Equity
167.22
128.37
(38.85)
1%
Preferred Stocks
431,244.00
428865 00
(2.379.00)
5%
Concentrated 8 Other Equity
203.386.00
199389.00
(3.997.00)
2%
Total Value
$898,142.29
$887,771.70
($10,370.59)
10%
Beginning
Market Value
Ending
Market Value
Change
Current
Asset Categories
In Value
Allocation
NI a diet Value/Cost
Current
Period Value
Market Vane
687,771.70
Tax Cost
764,967.39
Unrealized Gain LCGS
(77,195.69)
Estimated Annual Income
45,693.48
Accrued Di lends
1.65457
Yield
6.63%
Equity Detail
Non-US EQuaY
US SmalaMal Cap Equity
US Largo Cap Equity
Equity as a percentage of your portfolio - 10 %
Pretend Stocks
Concentrated a Omar Epupy
Price
Quantity
Value
Adjusted Tax Cost
Original Cost
Unrealized
Est. Annual Inc.
Gain/Loss
Accrued Div.
Yield
US Large Cap Equity
APACHE CORP
037411-10-5 APA
J.P.Morgan
81.38
95.000
7.731 10
11.403 30
(3.672 20)
64.60
0.84%
Page 4 of 29
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00048589
SDNY_GM_00317787
EFTA01521223
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.